What Attributes Do Sponsors Seek When Selecting Investigative Sites Capable of Recruiting Under-Represented Patient Populations to Participate in Clinical Trials? Can You Assess Sites Against the Attributes?

Friday, July 23, 2021

These topics will be explored in the MCC Patient Diversity Community of Practice Group virtual meetings on August 12 and September 9, 2021. During the August meeting, the group will review a draft list of attributes, add and/or modify the attributes and brainstorm about how to measure / assess site capabilities.

The September meeting will be held jointly with the MCC Site Selection and Start-Up Process Metrics work group for a broader discussion about today’s approaches to select sites capable of enrolling under-represented participants in clinical trials and explore opportunities to expand the selection criteria in the future.

MCC members can log in to the member portal to register for the sessions.

Not a member? Contact Terry Holland, MCC Membership Director, to discuss membership options.